Australia Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size & Outlook
Australia veterinary active pharmaceutical ingredients manufacturing market, 2018-2030 (US$M)
Related Markets
Australia veterinary active pharmaceutical ingredients manufacturing market highlights
- The Australia veterinary active pharmaceutical ingredients manufacturing market generated a revenue of USD 291.3 million in 2023 and is expected to reach USD 499.1 million by 2030.
- The Australia market is expected to grow at a CAGR of 8% from 2024 to 2030.
- In terms of segment, in house was the largest revenue generating service type in 2023.
- Contract Outsourcing is the most lucrative service type segment registering the fastest growth during the forecast period.
Veterinary active pharmaceutical ingredients manufacturing market data book summary
| Market revenue in 2023 | USD 291.3 million |
| Market revenue in 2030 | USD 499.1 million |
| Growth rate | 8% (CAGR from 2023 to 2030) |
| Largest segment | In house |
| Fastest growing segment | Contract Outsourcing |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | In House, Contract Outsourcing |
| Key market players worldwide | Zoetis Inc Class A, SeQuent Scientific, Ofichem Group, The Chem-Pro Group, Siflon Drugs & Pharmaceuticals, Vetpharma, Suanfarma Biotech, Menadiona, Excel Industries |
Other key industry trends
- In terms of revenue, Australia accounted for 3.4% of the global veterinary active pharmaceutical ingredients manufacturing market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China veterinary active pharmaceutical ingredients manufacturing market is projected to lead the regional market in terms of revenue in 2030.
- India is the fastest growing regional market in Asia Pacific and is projected to reach USD 905.2 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Veterinary Active Pharmaceutical Ingredients Manufacturing Market Scope
Veterinary Active Pharmaceutical Ingredients Manufacturing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Australia veterinary active pharmaceutical ingredients manufacturing market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to veterinary active pharmaceutical ingredients manufacturing market will help companies and investors design strategic landscapes.
In house was the largest segment with a revenue share of 65.57% in 2023. Horizon Databook has segmented the Australia veterinary active pharmaceutical ingredients manufacturing market based on in house, contract outsourcing covering the revenue growth of each sub-segment from 2018 to 2030.
The rising demand for animal healthcare products and pet ownership in Australia is predicted to grow substantially over the forecast period. According to the Australian Veterinary Association, over 69% of households in Australia own pets, among which 48% are dogs, followed by cats at 33%.
The Australian Pesticides and Veterinary Medicines Authority (APVMA) regulates all veterinary medicines and chemicals used in animal healthcare products and ensures their safety & effectiveness for animals and the environment.
This regulatory framework is expected to boost the demand for high-quality veterinary APIs in Australia. Furthermore, the strong presence of key market players, increasing R&D activities, and product innovation are likely to drive growth in the veterinary API manufacturing market in Australia.
Reasons to subscribe to Australia veterinary active pharmaceutical ingredients manufacturing market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Australia veterinary active pharmaceutical ingredients manufacturing market databook
-
Our clientele includes a mix of veterinary active pharmaceutical ingredients manufacturing market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Australia veterinary active pharmaceutical ingredients manufacturing market , including forecasts for subscribers. This country databook contains high-level insights into Australia veterinary active pharmaceutical ingredients manufacturing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Australia veterinary active pharmaceutical ingredients manufacturing market size, by service type, 2018-2030 (US$M)
Australia Veterinary Active Pharmaceutical Ingredients Manufacturing Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
